When was Creative Diagnostics founded?

Creative Diagnostics was founded in 2005.

Where is Creative Diagnostics located?

Creative Diagnostics is headquartered in Shirley, United States.

How many employees does Creative Diagnostics have?

As of Apr 30, 2026, the latest employee count at Creative Diagnostics is 6.

Is Creative Diagnostics a funded company?

Creative Diagnostics is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Creative Diagnostics rank among its competitors?

Creative Diagnostics ranks 42nd amongst 280 active competitors, of which 16 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Y-Biologics, which secured $25.2M in Aug, 2025.

Who are the top competitors of Creative Diagnostics?

Creative Diagnostics' top competitors include Sino Biological, Y-Biologics and GenScript. Among them, Y-Biologics secured the most recent funding round in August, 2025.

Creative Diagnostics - 2026 Company Profile, Team & Competitors

Company Details

Antibodies, antigens, ELISA kits, and services for life science research. A manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components, and critical assay reagents. They provide contract biologic R&D and manufacturing services to diagnostic manufacturers, along with GMP biologics manufacturing for the biopharmaceutical market. They assist clients with rapidly developing, manufacturing, and commercializing point of care lateral flow, flow through, and ELISA assays. Specialties include producing fluorescent, visual colloidal gold, and paramagnetic labels, and highly sensitive, quantitative, and reader-based tests. They offer antigen generation, antibody generation, contract assay development, antibody modification, immunocytochemistry, analytical, and immunoprecipitation services. Platforms include Chemiluminescent Immunoassays (CLIA), Lateral Flow Immunoassay (LFIA), and Enzyme-Linked Immunosorbent Assays (ELISA). They also focus on pharmaceutical and diagnostic testing platforms, antibody discovery & development platforms, and antigen design & presentation platforms.

Website: www.creative-Diagnostics.com/
Social
Phone Number: +1 **********

Key Metrics

Founded Year

2005

Location

Shirley, United States

Stage

Public

Ranked

42^nd among 280 active competitors

Employee Count

6 as on Apr 30, 2026

Similar Companies

Sino Biological & 336 more

Exit Details

Public

View Creative Diagnostics' full profile

Creative Diagnostics has not raised any funding rounds yet.

The founders of Creative Diagnostics is Emily Dean.

Here are the details of Creative Diagnostics' key team members:

Emily Dean: Founder of Creative Diagnostics.

View details of Creative Diagnostics's Founder profiles and Board Members

Creative Diagnostics' employee count trend

Creative Diagnostics has 6 employees as of Apr 26. Here is Creative Diagnostics's employee count trend over the years:

Employee count trend for Creative Diagnostics

Uncover Creative Diagnostics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Creative Diagnostics include Sino Biological, Y-Biologics and GenScript. Here is the list of Top 10 competitors of Creative Diagnostics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Sino Biological 2007, Beijing (China), Series A	Provider of reagents,and kits for clinical research	$29.4M	Qiming Venture Partners, CTS Capital & 1 others	67/100
2nd	Y-Biologics 2007, Daejeon (South Korea), Public	Developer of antibodies for the treatment of multiple diseases	$42.1M	InterVest, IMM Investment & 14 others	56/100
3rd	GenScript 2002, Piscataway (United States), Public	Provider of reagents and instruments for life sciences research	$15M	Kleiner Perkins, Vermögensclub & 1 others	55/100
4th	Shanghai OPM Biosciences 2013, Pudong (China), Series B	Antibody culture media and vaccine culture products developer	$14.4M	CPE, China Life Great Health Fund & 5 others	54/100
5th	Allele Biotech 1999, San Diego (United States), Series B	cGMP iPSCs and cell therapy CDMO accelerating regenerative medicine programs	$18M	NIH, HHS & 1 others	53/100
6th	Mabtech 1986, Nacka (Sweden), Acquired	Develops antibodies and ELISA kits	-	Merieux Equity Partners, IK Partners & 1 others	52/100
7th	ITBMed 2016, Stockholm (Sweden), Series A	Developer of monoclonal antibodies to prevent transplant rejections	$87M	3E Bioventures Capital, Yonjin Capital & 2 others	51/100
8th	Pixelgen Technolgies 2020, Stockholm (Sweden), Series A	Developer of ground-breaking technologies for biomedical research and diagnostics	$6M	Industrifonden, Navigare Ventures & 1 others	50/100
9th	Immuno-Biological Laboratories 1982, Fujioka (Japan), Public	Manufacture antibodies	-	Japan Asia Investment, Hokkaido Venture Capital ... & 3 others	49/100
10th	Antibodies.com 2015, Cambridge (United Kingdom), Seed	Provider of portfolio of diagnostic reagents	$506K	Nidobirds Venture, Torianna Consultants & 8 others	49/100
42nd	Creative Diagnostics 2005, Shirley (United States), Public	Antibodies, antigens, ELISA kits, and services for life science research	-	-	32/100